Factors for starting JAKi compared with bDMARDs using binary logistic regression (n = 439).

Figshare2023-01-10 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Factors_for_starting_JAKi_compared_with_bDMARDs_using_binary_logistic_regression_n_439_/21860446 数据链接链接失效反馈

官方服务：

资源简介：

Factors for starting JAKi compared with bDMARDs using binary logistic regression (n = 439).

创建时间：

2023-01-10

Methodological quality of head-to-head studies comparing ranibizumab with bevacizumab (direct comparison).

药物疗效比较

质量评估方法学

AE: Adverse effects.*The CATT showed only minor differences in the socioeconomic status and in the history of myocardial infarction between the randomised groups.#Outcome assessor and care provider bl

Figshare2015-12-02 更新70

BOLALARDA YO'TAL BILAN O'TKIR RESPIRATOR KASALLIKLARNI DAVOLASHDA KOMBINATSIYALASHGAN PREPARATNING SAMARADORLIGINI BAHOLASH

呼吸疾病治疗

药物疗效比较

V state provedeno sravnitelnoye issledovaniye klinicheskoy effektivnosti preparatov Bronxipret i Ambroksol pri lechenii kaxlya u detey s ostrimi respiratornimi infeksiyami (ORI). Preparatlarning samar

Zenodo2026-03-13 更新60

Supplementary Material for: Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention - analysis from the Acute Coronary Syndrome Israeli Survey (ACSIS)

药物疗效比较

急性冠状动脉综合征

Introduction: We aimed to compare the outcomes of ACS (acute coronary syndrome) patients undergoing in-hospital PCI (percutaneous coronary intervention) treated with prasugrel versus ticagrelor. Metho

Figshare2021-11-22 更新20

Supplementary materials: Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema

药物疗效比较

遗传性血管性水肿

These are peer-reviewed supplementary materials for the article ' Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatm

DataCite Commons2026-04-29 更新70

First-line targ veted therapies of advanced hepatocellular carcinoma: A Bayesian network analysis of randomized controlled trials

癌症靶向治疗

药物疗效比较

Purpose A variety of targeted drug were developed and proved effective and safe in clinical trials. Our study aims to compare the efficacies and safety of different targeted drugs in advanced hepatoce

NIAID Data Ecosystem50

Factors for starting JAKi compared with bDMARDs using binary logistic regression (n = 439).

资源简介：

相关数据集